Modulation of p-glycoprotein transport function at the blood-brain barrier.
about
The biological significance of brain barrier mechanisms: help or hindrance in drug delivery to the central nervous system?Physiology and pathophysiology of the blood-brain barrier: P-glycoprotein and occludin trafficking as therapeutic targets to optimize central nervous system drug deliveryDiesel exhaust particles induce oxidative stress, proinflammatory signaling, and P-glycoprotein up-regulation at the blood-brain barrierSpecific increase in MDR1 mediated drug-efflux in human brain endothelial cells following co-exposure to HIV-1 and saquinavirTRPV1 activation results in disruption of the blood-brain barrier in the ratNeuroinflammation activates Mdr1b efflux transport through NFkappaB: promoter analysis in BBB endotheliaP-glycoprotein acts as an immunomodulator during neuroinflammation.High glucose decreases expression and activity of p-glycoprotein in cultured human retinal pigment epithelium possibly through iNOS induction.The biology of brain metastases-translation to new therapiesImmunological response as a source to variability in drug metabolism and transport.Sagopilone crosses the blood-brain barrier in vivo to inhibit brain tumor growth and metastasesMechanisms of the penetration of blood-borne substances into the brain.P-glycoprotein trafficking at the blood-brain barrier altered by peripheral inflammatory hyperalgesia.A Role for P-Glycoprotein in Clearance of Alzheimer Amyloid β -Peptide from the Brain.NanoART, neuroAIDS and CNS drug delivery.Nanoparticle-based drug delivery to improve the efficacy of antiretroviral therapy in the central nervous systemTau as a therapeutic target for Alzheimer's diseaseThe blood-brain barrier: an engineering perspective.The Role of Nanoparticle in Brain Permeability: An in-vitro BBB Model.Induction of Drug Transporters Alters Disposition of Risperidone - A Study in MiceExpression and induction of p-glycoprotein-1 on cultured human brain endothelium.Qualitative prediction of blood-brain barrier permeability on a large and refined dataset.Posterior Reversible Encephalopathy Syndrome during Recovery from Acute Kidney Injury after Hepatitis A Infection.Computational and Pharmacological Target of Neurovascular Unit for Drug Design and Delivery.Decreased blood-brain barrier permeability to fluorescein in streptozotocin-treated rats.Association of ABCB1 Gene Polymorphisms with Efficacy and Adverse Reaction to Risperidone or Paliperidone in Han Chinese Schizophrenic Patients.P-glycoprotein (ABCB1) and Oxidative Stress: Focus on Alzheimer's Disease.Metabolism and Distribution of Clozapine-N-oxide: Implications for Nonhuman Primate Chemogenetics.Amyloid-β contributes to blood-brain barrier leakage in transgenic human amyloid precursor protein mice and in humans with cerebral amyloid angiopathy.Relationship between therapeutic efficacy of doxorubicin-transferrin conjugate and expression of P-glycoprotein in chronic erythromyeloblastoid leukemia cells sensitive and resistant to doxorubicin.
P2860
Q26753140-8B230E8D-48EB-445B-900C-6F7486C5A747Q26861408-5D9B3340-3863-49FE-9AB4-CA332BF1B08BQ28385084-AEE35B92-53FD-4E68-997D-386C50E8340EQ28534049-D7D012C3-F908-4EE6-953A-9FBF90E68A58Q28577575-7AE7F90D-02CE-444F-BE38-D6B96C155B93Q28578682-459FC4B4-715F-48AE-A04B-782AEEE6DF4DQ30973736-80BD94F3-8934-4737-B1B9-B354796F33E0Q34171201-62523CDC-E91C-4FF1-BE7A-E42D2643A7D2Q35676602-62D8AB43-FF3C-419F-801A-424AB7948F16Q35749503-50F2C1B2-6E25-4907-8ACE-2367AE6D5F18Q37284300-F09B94C1-648B-4A01-BF6E-40C3592E8F8FQ37313443-5B0E5185-2A3B-425B-8263-F9C9A3EA0032Q37364487-698F8C22-007C-480A-8C8E-AEFBEE3FAC39Q37403948-FEEF408C-24DF-4619-BC3C-1EDCAF5A63E7Q37538776-93E52046-CD2C-4E13-9864-49A4E05D0A3BQ37698620-05276932-6BD8-4C5B-9525-B6AACADD8B01Q37890451-3424E6AB-7CAF-4DEC-9313-F0D702A74B29Q38134725-353D20D6-9742-431D-A200-88C5F096F24FQ38745356-14244505-4477-433F-A005-197437CFD223Q38753518-B387F2DA-8CBA-4ED8-86D8-740894271612Q39819640-819507A7-1F52-4692-BD2E-93A5B8E611D0Q39896264-84A2DA11-47B6-4507-BF7F-BCEE3F30E038Q40266225-FD47D138-CAAC-4A80-8F0B-740C68B59985Q41886870-C788464D-7B3B-449D-BE2C-1554DE7F70C5Q41941900-2DCACE16-83EE-4BA4-9D73-C15DC9893E23Q47133433-CB8A63AE-5411-4013-9576-D32A68BCBDD0Q47873232-1E160152-2885-4558-903A-158482D07BE1Q48096641-4DFCD2E5-83EC-42F9-8C35-D50106B65C73Q49409019-168BEB96-C399-4875-9D8D-5D5DB6D5D483Q55105383-F4A3A366-BD58-40B4-A017-E38DF011EE69
P2860
Modulation of p-glycoprotein transport function at the blood-brain barrier.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Modulation of p-glycoprotein transport function at the blood-brain barrier.
@ast
Modulation of p-glycoprotein transport function at the blood-brain barrier.
@en
type
label
Modulation of p-glycoprotein transport function at the blood-brain barrier.
@ast
Modulation of p-glycoprotein transport function at the blood-brain barrier.
@en
prefLabel
Modulation of p-glycoprotein transport function at the blood-brain barrier.
@ast
Modulation of p-glycoprotein transport function at the blood-brain barrier.
@en
P2093
P2860
P1476
Modulation of p-glycoprotein transport function at the blood-brain barrier.
@en
P2093
Anika M S Hartz
Björn Bauer
Gert Fricker
P2860
P304
P356
10.1177/153537020523000206
P577
2005-02-01T00:00:00Z